AI-based process analytics platform to increase productivity and quality in manual shop-floor processes. Processes are captured using computer vision and automatically analysed with a highly flexible AI to identify improvement potential.
Cambrium's mission is to trigger the next wave of material innovation by harnessing nature’s protein building blocks. Our platform combines synthetic biology, machine learning and lab automation to create high-performance materials at scale. We fundamentally believe that the ability to align economic and environmental incentives makes biology the most important manufacturing technology of the 21st century. We are accelerating a Cambrian explosion of biomaterials to address the world’s most pressing problems.
Merantix Capital is a Berlin-based venture capital firm and a unit of Merantix, a group of companies and initiatives driving AI forward in Europe. We leverage our platform to attract and foster interactions between ideas, talent, industry, and policy. We combine our venture-building DNA, deep AI investing expertise, and our expansive community.
Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.
